Perioperative Period is a Critical Gap for Minimal Residual Cancer Cells Progression and Therapy: Biological and Molecular Based Evidences
Journal: Journal of Hematology and Oncology Research (Vol.3, No. 2)Publication Date: 2018-10-04
Authors : Anwar Tawfik Amin; Norio Shiraishi; Seigo Kitano;
Page : 1-13
Keywords : surgical stress; pain and cancer recurrence; surgery induced immune suppression; tumor growth;
Abstract
Although surgery is the main treatment for solid tumors, it could enhance the growth and metastasis of minimal residual cancer. In this review article we have discussed the perioperative changes in cancer cells and surrounding environment as well as the alterations in the immune system. Several trials are ongoing to develop new diagnostic and therapeutic options for minimal residual cancer after surgery.
Other Latest Articles
- Clinical and Laboratory Predictors of Elevated TRV In Sickle Cell Anaemia
- Clinical Evaluation of Significance of 25(Oh)D Levels in Patients with Organophosphorus Poisoning
- Growth Pattern of Saccharomyces cerevisiae in Cassava Mill Effluents
- The Environmental Impact of Etelebou Flow Station In Surface Water of Gbarain, Bayelsa State, Nigeria
- Acute and Subacute Toxicity Evaluation of the Stem Bark Aqueous Extract of Harungana Madagascariensis in Rodents
Last modified: 2018-10-13 14:27:07